|
US3180193A
(en)
|
1963-02-25 |
1965-04-27 |
Benedict David |
Machines for cutting lengths of strip material
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4694778A
(en)
|
1984-05-04 |
1987-09-22 |
Anicon, Inc. |
Chemical vapor deposition wafer boat
|
|
US4675287A
(en)
|
1984-07-26 |
1987-06-23 |
Scripps Clinic And Research Foundation |
Monoclonal antibody directed to human ganglioside GD2
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
WO1988001649A1
(en)
|
1986-09-02 |
1988-03-10 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
EP0295305A4
(en)
|
1986-09-19 |
1989-12-28 |
Meiji Milk Products Company Lt |
MONOCLONAL ANTIBODY SPECIFIC TO THE SURFACE GANGLIOSIDE OF TUMOR CELLS AND HYBRIDOMA PRODUCING THE SAME.
|
|
EP0307434B2
(en)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Altered antibodies
|
|
ATE108965T1
(de)
|
1987-12-09 |
1994-08-15 |
Omron Tateisi Electronics Co |
Induktives datenübertragungssystem.
|
|
US5476996A
(en)
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US6750325B1
(en)
|
1989-12-21 |
2004-06-15 |
Celltech R&D Limited |
CD3 specific recombinant antibody
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
ES2284161T3
(es)
|
1990-01-12 |
2007-11-01 |
Amgen Fremont Inc. |
Generacion de anticuerpos xenogenicos.
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
AU8507191A
(en)
|
1990-08-29 |
1992-03-30 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
DE69133557D1
(de)
|
1990-08-29 |
2007-03-15 |
Pharming Intellectual Pty Bv |
Homologe rekombination in säugetier-zellen
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
WO1992022670A1
(en)
|
1991-06-12 |
1992-12-23 |
Genpharm International, Inc. |
Early detection of transgenic embryos
|
|
WO1992022645A1
(en)
|
1991-06-14 |
1992-12-23 |
Genpharm International, Inc. |
Transgenic immunodeficient non-human animals
|
|
ATE255131T1
(de)
|
1991-06-14 |
2003-12-15 |
Genentech Inc |
Humanisierter heregulin antikörper
|
|
GB9117522D0
(en)
|
1991-08-14 |
1991-10-02 |
Medical Res Council |
Ligands for dendritic cells, their uses and production
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
AU3328493A
(en)
|
1991-12-17 |
1993-07-19 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
CA2135313A1
(en)
|
1992-06-18 |
1994-01-06 |
Theodore Choi |
Methods for producing transgenic non-human animals harboring a yeast artificial chromosome
|
|
ES2301158T3
(es)
|
1992-07-24 |
2008-06-16 |
Amgen Fremont Inc. |
Produccion de anticuerpos xenogenicos.
|
|
US5981175A
(en)
|
1993-01-07 |
1999-11-09 |
Genpharm Internation, Inc. |
Methods for producing recombinant mammalian cells harboring a yeast artificial chromosome
|
|
AU6819494A
(en)
|
1993-04-26 |
1994-11-21 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625825A
(en)
|
1993-10-21 |
1997-04-29 |
Lsi Logic Corporation |
Random number generating apparatus for an interface unit of a carrier sense with multiple access and collision detect (CSMA/CD) ethernet data network
|
|
IT1271461B
(it)
|
1993-12-01 |
1997-05-28 |
Menarini Ricerche Sud Spa |
Anticorpo monoclonale bispecifico anti-cd3/anti-egfr,processo per la produzione e suo uso.
|
|
GB9401182D0
(en)
|
1994-01-21 |
1994-03-16 |
Inst Of Cancer The Research |
Antibodies to EGF receptor and their antitumour effect
|
|
ES2191702T3
(es)
|
1994-03-17 |
2003-09-16 |
Merck Patent Gmbh |
Fv monocatenarios anti-egfr y anticuerpos anti-egfr.
|
|
US5643763A
(en)
|
1994-11-04 |
1997-07-01 |
Genpharm International, Inc. |
Method for making recombinant yeast artificial chromosomes by minimizing diploid doubling during mating
|
|
US5977316A
(en)
|
1995-01-17 |
1999-11-02 |
The Board Of Trustees Of The University Of Kentucky |
Monoclonal antibody 1A7 and related polypeptides
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
EP0822830B1
(en)
|
1995-04-27 |
2008-04-02 |
Amgen Fremont Inc. |
Human anti-IL-8 antibodies, derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
|
ATE219517T1
(de)
|
1995-08-18 |
2002-07-15 |
Morphosys Ag |
Protein-/(poly)peptidbibliotheken
|
|
CA2230759C
(en)
|
1995-08-29 |
2012-02-21 |
Kirin Beer Kabushiki Kaisha |
Chimeric animal and method for producing the same
|
|
US5783186A
(en)
|
1995-12-05 |
1998-07-21 |
Amgen Inc. |
Antibody-induced apoptosis
|
|
WO1997027873A1
(en)
|
1996-01-30 |
1997-08-07 |
Brigham & Women's Hospital, Inc. |
Antibodies for modulating cd47-mediated neutrophil transmigration
|
|
ATE549918T1
(de)
|
1996-12-03 |
2012-04-15 |
Amgen Fremont Inc |
Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
|
|
US20020076695A1
(en)
|
1997-04-04 |
2002-06-20 |
Jeffrey S. Ross |
Methods for treating prostate cancer
|
|
WO1998052976A1
(en)
|
1997-05-21 |
1998-11-26 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
US7254167B2
(en)
|
1998-10-30 |
2007-08-07 |
Broadcom Corporation |
Constellation-multiplexed transmitter and receiver
|
|
EP1051432B1
(en)
|
1998-12-08 |
2007-01-24 |
Biovation Limited |
Method for reducing immunogenicity of proteins
|
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
|
GB9917012D0
(en)
|
1999-07-20 |
1999-09-22 |
Pharmacia & Upjohn Spa |
Combined preparations comprising antitumor agents
|
|
NZ527977A
(en)
|
2001-02-12 |
2005-10-28 |
Medarex Inc |
Human monoclonal antibodies to FC alpha receptor (CD89)
|
|
KR20030074839A
(ko)
|
2001-02-19 |
2003-09-19 |
메르크 파텐트 게엠베하 |
감소된 면역원성을 갖는 개질 항-ｅｇｆｒ 항체
|
|
CA2438682A1
(en)
|
2001-02-20 |
2002-08-29 |
Zymogenetics, Inc. |
Antibodies that bind both bcma and taci
|
|
US7230167B2
(en)
|
2001-08-31 |
2007-06-12 |
Syngenta Participations Ag |
Modified Cry3A toxins and nucleic acid sequences coding therefor
|
|
EP3698626A1
(en)
|
2001-11-30 |
2020-08-26 |
Amgen Fremont Inc. |
Transgenic animals bearing human ig lambda light chain genes
|
|
AU2002360525A1
(en)
|
2001-12-06 |
2003-06-23 |
University Of Florida |
Targeting leukemia cells
|
|
JP4472351B2
(ja)
|
2002-03-01 |
2010-06-02 |
イミューノメディクス、インコーポレイテッド |
インターナライジング抗ｃｄ７４抗体およびその使用方法
|
|
US8486859B2
(en)
|
2002-05-15 |
2013-07-16 |
Bioenergy, Inc. |
Use of ribose to enhance plant growth
|
|
US7904068B2
(en)
|
2003-06-06 |
2011-03-08 |
At&T Intellectual Property I, L.P. |
System and method for providing integrated voice and data services utilizing wired cordless access with unlicensed spectrum and wired access with licensed spectrum
|
|
US7288638B2
(en)
|
2003-10-10 |
2007-10-30 |
Bristol-Myers Squibb Company |
Fully human antibodies against human 4-1BB
|
|
CN1898267B
(zh)
|
2003-11-01 |
2012-05-23 |
默克专利股份有限公司 |
修饰的抗cd52抗体
|
|
CA2545166A1
(en)
|
2003-11-11 |
2005-05-19 |
Chugai Seiyaku Kabushiki Kaisha |
Humanized anti-cd47 antibody
|
|
CA2560919A1
(en)
|
2004-03-26 |
2005-10-06 |
Pfizer Products Inc. |
Uses of anti-ctla-4 antibodies
|
|
EP1626059A1
(en)
|
2004-08-09 |
2006-02-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2
|
|
EP1793858A4
(en)
|
2004-09-08 |
2008-12-10 |
Univ Ohio State Res Found |
HUMAN MONOCLONAL ANTI-CTLA4 ANTIBODIES FOR CANCER TREATMENT
|
|
US20120294863A1
(en)
|
2004-10-15 |
2012-11-22 |
Seattle Genetics, Inc. |
Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune Disorders
|
|
DE102004063494A1
(de)
|
2004-12-23 |
2006-07-13 |
Tegenero Ag |
Antikörper
|
|
WO2006088464A2
(en)
|
2005-02-15 |
2006-08-24 |
Gtc Biotherapeutics, Inc. |
A method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetection
|
|
US20080019905A9
(en)
|
2005-02-18 |
2008-01-24 |
Strome Scott E |
Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
|
|
EP2228698B1
(en)
|
2005-03-14 |
2012-06-27 |
Omron Corporation |
Programmable controller system
|
|
RU2415871C2
(ru)
|
2005-03-31 |
2011-04-10 |
Байомедикс Инк. |
Моноклональное анти-cd20-антитело
|
|
EP1871418B1
(en)
|
2005-04-19 |
2014-03-19 |
Seattle Genetics, Inc. |
Humanized anti-cd70 binding agents and uses thereof
|
|
US8234145B2
(en)
|
2005-07-12 |
2012-07-31 |
International Business Machines Corporation |
Automatic computation of validation metrics for global logistics processes
|
|
BRPI0604215A
(pt)
|
2005-08-17 |
2007-04-10 |
Biosigma Sa |
método para projetar oligonucleotìdeos para técnicas de biologia molecular
|
|
JP4860703B2
(ja)
|
2005-10-06 |
2012-01-25 |
ゼンコー・インコーポレイテッド |
最適化された抗ｃｄ３０抗体
|
|
JP2007122396A
(ja)
|
2005-10-27 |
2007-05-17 |
Hitachi Ltd |
ディスクアレイ装置及びその障害対応検証方法
|
|
TWI461436B
(zh)
|
2005-11-25 |
2014-11-21 |
Kyowa Hakko Kirin Co Ltd |
人類ｃｄ１３４（ｏｘ４０）之人類單株抗體及其製造及使用方法
|
|
US7919297B2
(en)
|
2006-02-21 |
2011-04-05 |
Cornell Research Foundation, Inc. |
Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase
|
|
US7574748B2
(en)
|
2006-03-07 |
2009-08-18 |
Nike, Inc. |
Glove with support system
|
|
US7990860B2
(en)
|
2006-06-16 |
2011-08-02 |
Harris Corporation |
Method and system for rule-based sequencing for QoS
|
|
ES2656359T3
(es)
|
2006-06-30 |
2018-02-26 |
Novo Nordisk A/S |
Anticuerpos anti-NKG2A y usos de los mismos
|
|
US8430938B1
(en)
|
2006-07-13 |
2013-04-30 |
The United States Of America As Represented By The Secretary Of The Navy |
Control algorithm for autothermal reformer
|
|
KR101146588B1
(ko)
|
2006-08-11 |
2012-05-16 |
삼성전자주식회사 |
Ｆｉｎ 구조체 및 이를 이용한 핀 트랜지스터의 제조방법
|
|
CN100589507C
(zh)
|
2006-10-30 |
2010-02-10 |
华为技术有限公司 |
一种拨号提示系统及方法
|
|
US20100136030A1
(en)
|
2007-02-27 |
2010-06-03 |
Lamhamedi-Cherradi Salah-Eddine |
Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
|
|
US7466008B2
(en)
|
2007-03-13 |
2008-12-16 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
BiCMOS performance enhancement by mechanical uniaxial strain and methods of manufacture
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
US9244059B2
(en)
|
2007-04-30 |
2016-01-26 |
Immutep Parc Club Orsay |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
WO2009006520A1
(en)
|
2007-07-03 |
2009-01-08 |
Medimmune, Llc |
Hinge domain engineering
|
|
ATE543835T1
(de)
|
2007-07-16 |
2012-02-15 |
Genentech Inc |
Anti-cd79b-antikörper und immunkonjugate und anwendungsverfahren
|
|
US20090028857A1
(en)
|
2007-07-23 |
2009-01-29 |
Cell Genesys, Inc. |
Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
|
|
US8209741B2
(en)
|
2007-09-17 |
2012-06-26 |
Microsoft Corporation |
Human performance in human interactive proofs using partial credit
|
|
US8464584B2
(en)
|
2007-10-19 |
2013-06-18 |
Food Equipment Technologies Company, Inc. |
Beverage dispenser with level measuring apparatus and display
|
|
WO2009067987A1
(de)
|
2007-11-29 |
2009-06-04 |
Luk Lamellen Und Kupplungsbau Beteiligungs Kg |
Kraftübertragungsvorrichtung, insbesondere zur leistungsübertragung zwischen einer antriebsmaschine und einem abtrieb
|
|
DK2222706T4
(en)
|
2007-12-14 |
2016-11-21 |
Novo Nordisk As |
Antibodies that bind to NKG2D and its use
|
|
US8376279B2
(en)
|
2008-01-23 |
2013-02-19 |
Aurora Flight Sciences Corporation |
Inflatable folding wings for a very high altitude aircraft
|
|
CN101952317B
(zh)
|
2008-01-24 |
2015-07-22 |
诺沃-诺迪斯克有限公司 |
人化抗-人nkg2a单克隆抗体
|
|
PT2247620T
(pt)
|
2008-01-31 |
2016-08-23 |
Genentech Inc |
Anticorpos e imunoconjugados anti-cd79b e métodos de utilização
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
KR101050829B1
(ko)
|
2008-10-02 |
2011-07-20 |
서울대학교산학협력단 |
항 ｐｄ-1 항체 또는 항 ｐｄ-ｌ1 항체를 포함하는 항암제
|
|
CN102341172A
(zh)
|
2009-03-04 |
2012-02-01 |
日产自动车株式会社 |
废气净化催化剂及其制造方法
|
|
BRPI1012560A2
(pt)
|
2009-04-01 |
2016-07-26 |
Genentech Inc |
anticorpos anti-fcrh5 e imunoconjugados e métodos de uso
|
|
US8463191B2
(en)
|
2009-04-02 |
2013-06-11 |
Qualcomm Incorporated |
Beamforming options with partial channel knowledge
|
|
ES2571235T3
(es)
|
2009-04-10 |
2016-05-24 |
Kyowa Hakko Kirin Co Ltd |
Procedimiento para el tratamiento de un tumor sanguíneo que utiliza el anticuerpo anti-TIM-3
|
|
US20120288499A1
(en)
|
2010-01-15 |
2012-11-15 |
Armand Bensussan |
Methods for diagnosis and treatment of cutaneous t cell lymphomas
|
|
EP2542258A4
(en)
|
2010-03-04 |
2013-08-21 |
Vet Therapeutics Inc |
ON CD52 MONOCLONAL ANTIBODIES
|
|
TW201134488A
(en)
|
2010-03-11 |
2011-10-16 |
Ucb Pharma Sa |
PD-1 antibodies
|
|
EP2545078A1
(en)
|
2010-03-11 |
2013-01-16 |
UCB Pharma, S.A. |
Pd-1 antibody
|
|
PL2575881T3
(pl)
|
2010-05-28 |
2018-06-29 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Przeciwciała swoiste wobec CD160 do leczenia zaburzeń oczu związanych z angiogenezą
|
|
WO2011155607A1
(ja)
|
2010-06-11 |
2011-12-15 |
協和発酵キリン株式会社 |
抗ｔｉｍ－３抗体
|
|
WO2012027328A2
(en)
|
2010-08-23 |
2012-03-01 |
Board Of Regents, The University Of Texas System |
Anti-ox40 antibodies and methods of using the same
|
|
CN103298648B
(zh)
|
2010-12-30 |
2016-04-13 |
C.劳勃.汉默斯坦两合有限公司 |
适于机动车辆座椅的包括两对导轨的纵向调节装置
|
|
EP2670440B1
(en)
|
2011-02-01 |
2018-09-05 |
Genmab A/S |
Human antibodies and antibody-drug conjugates against cd74
|
|
US20120269827A1
(en)
|
2011-04-01 |
2012-10-25 |
Immunogen, Inc. |
Compositions and Methods for Treatment of Ovarian, Peritoneal, and Fallopian Tube Cancer
|
|
HRP20180858T1
(hr)
|
2011-07-11 |
2018-09-21 |
Glenmark Pharmaceuticals S.A. |
Protutijela koja se vežu na ox40 i njihove uporabe
|
|
KR101685262B1
(ko)
|
2011-08-23 |
2016-12-21 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
항-ｏｘ４０ 항체 및 이의 사용 방법
|
|
JP2013193995A
(ja)
|
2012-03-21 |
2013-09-30 |
Tokyo Medical & Dental Univ |
特発性炎症性筋疾患の予防又は治療剤
|
|
EP2841459A4
(en)
|
2012-04-26 |
2016-04-13 |
Bioatla Llc |
ANTI-CD22 ANTIBODIES
|
|
WO2014022758A1
(en)
|
2012-08-03 |
2014-02-06 |
Dana-Farber Cancer Institute, Inc. |
Single agent anti-pd-l1 and pd-l2 dual binding antibodies and methods of use
|
|
BR112015007672A2
(pt)
|
2012-10-04 |
2017-08-08 |
Dana Farber Cancer Inst Inc |
anticorpos anti-pd-l1 monoclonais humanos e métodos de uso
|
|
ES2937015T3
(es)
|
2012-11-01 |
2023-03-23 |
Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft |
Anticuerpo contra CD269 (BCMA)
|
|
US9221908B2
(en)
|
2012-12-12 |
2015-12-29 |
Vasculox, Inc. |
Therapeutic CD47 antibodies
|
|
WO2014158821A1
(en)
|
2013-03-12 |
2014-10-02 |
Imaginab, Inc. |
Antigen binding constructs to cd70
|
|
WO2014164067A1
(en)
|
2013-03-12 |
2014-10-09 |
Imaginab, Inc. |
Antigen binding constructs to cd30
|
|
CN105658206A
(zh)
|
2013-06-03 |
2016-06-08 |
诺华股份有限公司 |
抗pd-l1抗体与mek抑制剂和/或braf抑制剂的组合
|
|
AU2015210750B2
(en)
|
2014-01-31 |
2020-08-20 |
Children's Medical Center Corporation |
Antibody molecules to TIM-3 and uses thereof
|
|
US9944709B2
(en)
|
2014-03-19 |
2018-04-17 |
Cellectis |
CD123 specific chimeric antigen receptors for cancer immunotherapy
|
|
US20170028062A1
(en)
|
2014-04-07 |
2017-02-02 |
Seattle Genetics, Inc. |
Stable formulations for anti-cd19 antibodies and antibody-drug conjugates
|
|
EP2930188A1
(en)
|
2014-04-13 |
2015-10-14 |
Affimed Therapeutics AG |
Trifunctional antigen-binding molecule
|
|
KR102526945B1
(ko)
|
2014-04-30 |
2023-04-27 |
막스-델부뤽-센트럼 퓌어 몰레쿨라레 메디친 인 데어 헬름홀츠-게마인샤프트 |
Ｃｄ269에 대한 인간화 항체
|
|
RU2017105425A
(ru)
|
2014-08-28 |
2018-09-28 |
Академиш Зикенхёйс Лейден Х.О.Д.Н. Люмк |
Комбинации антитела против cd94/nkg2a и/или cd94/nkg2b и вакцины
|
|
EP3187583B1
(en)
|
2014-08-29 |
2023-04-26 |
National University Corporation Hokkaido University |
Monoclonal antibody against kir2ds1
|
|
US10105142B2
(en)
|
2014-09-18 |
2018-10-23 |
Ethicon Llc |
Surgical stapler with plurality of cutting elements
|
|
CN105837689B
(zh)
|
2015-01-13 |
2020-06-19 |
博生吉安科细胞技术有限公司 |
抗cd19单克隆抗体及其制备方法
|
|
EP3812398A3
(en)
|
2015-01-23 |
2021-07-21 |
Sanofi |
Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123
|
|
US10100118B2
(en)
|
2015-04-08 |
2018-10-16 |
Sorrento Therapeutics, Inc. |
Antibody therapeutics that bind CD123
|
|
US11174313B2
(en)
|
2015-06-12 |
2021-11-16 |
Alector Llc |
Anti-CD33 antibodies and methods of use thereof
|
|
WO2016209021A1
(ko)
|
2015-06-24 |
2016-12-29 |
주식회사 차바이오텍 |
자연살해세포의 증식 방법 및 자연살해세포 증식용 조성물
|
|
GB201601077D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibody molecule
|
|
WO2017023780A1
(en)
|
2015-07-31 |
2017-02-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibody-drug conjugates for targeting cd56-positive tumors
|
|
EA039859B1
(ru)
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
EP3156417A1
(en)
|
2015-10-13 |
2017-04-19 |
Affimed GmbH |
Multivalent fv antibodies
|
|
WO2017124002A1
(en)
*
|
2016-01-13 |
2017-07-20 |
Compass Therapeutics Llc |
Multispecific immunomodulatory antigen-binding constructs
|
|
CN109219618B
(zh)
|
2016-01-21 |
2022-08-09 |
辉瑞大药厂 |
针对表皮生长因子受体变体iii和cd3的单特异性和双特异性抗体及其用途
|
|
MX2018009085A
(es)
|
2016-01-27 |
2019-05-09 |
Sutro Biopharma Inc |
Conjugados de anticuerpos anti-cd74, composiciones que comprenden conjugados de anticuerpos anti-cd74 y metodos de uso de congujados de anticuerpos anti-cd74.
|
|
CN105753986B
(zh)
|
2016-04-24 |
2019-12-10 |
赵磊 |
一类抗cd20靶向抗体及用途
|
|
CN109415440B
(zh)
|
2016-06-27 |
2022-12-06 |
莫佛塞斯公司 |
抗-cd19抗体制剂
|
|
US20180208653A1
(en)
|
2017-01-20 |
2018-07-26 |
Beth Israel Deaconess Medical Center |
Methods for enhancing an immune response
|
|
US20200095327A1
(en)
|
2017-02-08 |
2020-03-26 |
Dragonfly Therapeutics, Inc. |
Antibody heavy chain variable domains targeting the nkg2d receptor
|
|
JP2020510422A
(ja)
|
2017-02-28 |
2020-04-09 |
シアトル ジェネティックス， インコーポレイテッド |
抗ｔｉｇｉｔ抗体
|
|
EP3589654A1
(en)
|
2017-03-02 |
2020-01-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to nectin-4 and uses thereof
|
|
KR20190140943A
(ko)
|
2017-04-24 |
2019-12-20 |
메모리얼 슬로안 케터링 캔서 센터 |
항-cd33 항체 제제
|
|
CA3066953A1
(en)
|
2017-06-30 |
2019-01-03 |
Lentigen Technology, Inc. |
Human monoclonal antibodies specific for cd33 and methods of their use
|
|
US11512129B2
(en)
|
2017-09-29 |
2022-11-29 |
Jiangsu Hengrui Medicine Co., Ltd. |
TIGIT antibody, antigen-binding fragment thereof, and medical use thereof
|
|
US20200347130A1
(en)
|
2017-11-10 |
2020-11-05 |
Jiangsu Hengrui Medicine Co., Ltd. |
CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof
|
|
SG11202007482WA
(en)
|
2018-02-08 |
2020-09-29 |
Dragonfly Therapeutics Inc |
Antibody variable domains targeting the nkg2d receptor
|
|
WO2019164821A1
(en)
|
2018-02-20 |
2019-08-29 |
Memorial Sloan Kettering Cancer Center |
Anti-cd20 antibody and uses thereof
|
|
EP3774914A2
(en)
|
2018-04-13 |
2021-02-17 |
Affimed GmbH |
Nk cell engaging antibody fusion constructs
|
|
WO2020014482A1
(en)
|
2018-07-12 |
2020-01-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Affinity matured cd22-specific monoclonal antibody and uses thereof
|
|
RS65658B1
(sr)
|
2018-08-27 |
2024-07-31 |
Affimed Gmbh |
Kriokonzervirane nk ćelije prethodno punjene konstruktom antitela
|
|
US12195539B2
(en)
|
2018-10-25 |
2025-01-14 |
Jjp Biologics Sp. Z O.O. |
Anti-human CD89 antibodies and uses thereof
|
|
WO2020083406A1
(zh)
|
2018-10-26 |
2020-04-30 |
科济生物医药（上海）有限公司 |
靶向cll1的抗体及其应用
|
|
CN111116745B
(zh)
|
2018-11-01 |
2022-10-14 |
上海新理念生物医药科技有限公司 |
抗CD79b抗体、其药物偶联物及其应用
|
|
US12534526B2
(en)
|
2018-11-07 |
2026-01-27 |
Shanghai Hyamab Biotech Co., Ltd. |
NKG2A antibody, preparation method therefor and application thereof
|
|
BR112021009111A2
(pt)
|
2018-11-16 |
2021-08-24 |
Bristol-Myers Squibb Company |
Anticorpos anti-nkg2a e usos dos mesmos
|
|
EP3897851A2
(en)
*
|
2018-12-17 |
2021-10-27 |
Revitope Limited |
Twin immune cell engager
|
|
WO2020135426A1
(zh)
|
2018-12-24 |
2020-07-02 |
信达生物制药(苏州)有限公司 |
全人源的抗cd30单链抗体及其应用
|
|
GB2597851B
(en)
|
2019-02-21 |
2024-05-29 |
Marengo Therapeutics Inc |
Antibody molecules that bind to NKP30 and uses thereof
|